DocMorris AG (CHIX:DOCMZ) Cash And Cash Equivalents : CHF95 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG Cash And Cash Equivalents?

DocMorris AG's quarterly cash and cash equivalents increased from Dec. 2023 (CHF54.03 Mil) to Jun. 2024 (CHF105.11 Mil) but then stayed the same from Jun. 2024 (CHF105.11 Mil) to Dec. 2024 (CHF95.37 Mil).

DocMorris AG's annual cash and cash equivalents declined from Dec. 2022 (CHF126.04 Mil) to Dec. 2023 (CHF54.03 Mil) but then increased from Dec. 2023 (CHF54.03 Mil) to Dec. 2024 (CHF95.37 Mil).

DocMorris AG Cash And Cash Equivalents Historical Data

The historical data trend for DocMorris AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocMorris AG Cash And Cash Equivalents Chart

DocMorris AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

Get a 7-Day Free Trial

300.61

277.74

126.04

54.03

95.37

DocMorris AG Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial															126.04	199.71	54.03	105.11	95.37

DocMorris AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

DocMorris AG (CHIX:DOCMz) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

DocMorris AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of DocMorris AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

DocMorris AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (CHIX:DOCMz) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

0RRB:UK ZRE:Germany DOCM:Switzerland

Address

Walzmuhlestrasse 49, Frauenfeld, CHE, 8500

Website

https://www.zurrosegroup.com

DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.

DocMorris AG Headlines

No Headlines